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Copyright  Karamik K eosinophilic-scarce cytoplasm, small rounded oval nuclei, without definitions of nucleoles, thin-chromatine cells. Atypia, necrosis and mitosis were not observed in the tumor. Tumor cells were studied with immunohistochemical methods and stained strongly diffuse positive with CD 57 , diffuse positive WT 1 , negative EMA, negative Alpha-Methylacyl-Coa Racemase (AMACR), negative CD 10 , negative RCC, negative CK 7 and negative desmin. Accompanied by histopathologic and immunohistochemical findings, it was reported as "metanephric adenoma" (Figure 3 ).
Discussion
MA is a rarely observed benign-character renal tumor. MA is identified in females at 2 times the rate for males and affects people of wide age interval (5-83 years). Tumor size varies from 0.3 to 15 cm. While it is identified incidentally in half of cases, patients may present such conditions as flank pain, hematuria and palpable mass. In 12% of patients with MA erythrocystosis is identified [4] . Erythrocytosis was shown to develop via multiple cytokines secreted by tumor cells [5] . Additionally, though rare, there are cases reported with hypercalcemia and chyluria [6] [7] .
Histopathologically, differential diagnosis of this tumor generally includes Papillary Cell Renal Carcinoma (PCRC) and Wilm's Tumor (WT). The tumor macroscopically shows solid growth pattern, with a homogenous surface not containing necrosis and hemorrhage. Tumors are generally yellowish-white or gray in color and are surrounded by a capsule containing solid or cystic material [8] . Microscopically the tumor cell nuclei are oval and have a smooth appearance. The tumor does not include mitosis, but has a welldifferentiated adenomatous pattern. It is different from WT as it does not contain any blastema [2] . Immunohistochemistry shows diffuse strong staining especially for CD 57 , WT 1 and S 100 , while CK 7 is rare and EMA and AMACR are negatively stained. Negative staining with CD 56 differentiates the tumor from WT, while CK 7 and AMACR are usually not expressed or only focally expressed in MA which allows exclusion of PRCC [9] .
After definition of this rare entity, studies at molecular and genetic level are increasing continuously. The most common variations observed with MA are BRAF v600e gene mutation and 2p16 gene changes. A comprehensive study by Calio et al. identified BRAF v600e gene mutation in 41 out of 48 cases with MA [10] . It is thought that deletion of BRAF v600e and 2p gene shows synergic effect for development of MA [11] . Additionally gains in the 7th and 17th chromosome and loss of the Y chromosome were identified to have a role in development of this tumor, with these traits showing similarity to PCRC in terms of genetics [12] .
Radiologically there are a limited number of studies related to MA. The majority of these tumors are hyperechoic on ultrasonography, while they may also be observed as hypoechoic or isoechoic [13] . On color Doppler ultrasonography blood flow is not observed, or reduced. On computed tomography, these tumors have regular boundaries, and appear hyperdense compared to normal renal parenchyma. The peripheral section of the mass contains attenuation at a higher rate compared to the central section [14] . MA has higher calcification rates compared to other renal masses and on radiology these findings were stated to be an important clue [15] . Contrary to this, one study assessed 18 MA patients radiologically and identified calcification in only 1 patient. Again the same study divided the 18 patients into Macroscopic investigation of the partial nephrectomy specimen observed a dirty-white color tumor of 6x6x5.5 cm with lobule contours, separated from the adjacent tissues of the renal capsule by smooth boundaries. Microscopic investigation observed separation from non-tumoral renal parenchyma by a fibrous capsule and tumoral cellular proliferation formed of tightly packeted small a sinus and tubules. The tumor was uniform, comprised of slightly
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Copyright  Karamik K 10 with pure MA and 8 with MA with malignant component and emphasized that the most important determinant difference was enhancement pattern [8] . Radiologically it does not appear possible to differentiate these masses as malignant or benign yet.
The benign nature of MA has led to questions on whether a preoperative renal biopsy is necessary or not. When the literature is viewed, there are cases of diagnosis with Fine Needle Aspiration Biopsy (FNAB). Blanco et al. diagnosed MA from FNAB and 20 months follow-up showed that the mass was stable on imaging [16] . Again, the lack of a specific finding for MA on preoperative imaging makes patient choice for biopsy complicated. Additionally, treatment may be misdirected due to problems such as insufficient material from aspiration biopsy and pathological confusion of MA with WT and PRCC. An example of this is given by Barroca et al. who identified a mass on the right kidney with radiologically in an 8-year old male child applying with vomiting complaints. FNAB was identified Wilm's tumor, so the patient was administered chemotherapy. Then radical nephrectomy was performed. Pathological specimen reported as metanephric adenoma [17] . Thompson et al. in a study of 2675 patients showed that as the size of renal tumors increased the risk of malignancy increased [18] . In this study, 90% of tumors from 5 to 6 cm in size were malignant. In our case, due to the large tumor size FNAB was not performed.
Though MA is a benign mass, patients follow-up should be carefully undertaken. Renshaw et al. reported a 7-year old female child with paraortic, hiler and aortic bifurcation lymph node metastasis [19] . Death linked to tumor was also reported for a female patient with mixed MA containing sarcomatoid structure [20] .
Conclusion
MA is a rarely observed renal tumor. As it does not have specific radiological findings, diagnosis of this benign tumor is difficult, as in our case. This case report reveals the necessity of considering FNAB for special situations like solitary kidney even with a large size tumor to prevent unnecessary treatment.
